Parra-Giraldo, C. M. | IICIMED

Parra-Giraldo, C. M.

Publications

P270

J. Fungi 2023, 9, 430.

The mortality attributable to candidemia in C. auris is higher than that in other Candida species: Myth or reality? 

Alvarez-Moreno, CA. | Morales-López, S. | Rodriguez, G. J. | Rodriguez, J. Y. | Robert, E. | Picot, C. | Ceballos-Garzon, A. | Parra-Giraldo, C. M. | Le Pape, P.

https://doi.org/10.3390/jof9040430

P249

PLoS One 2022. 

CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata. 

Ceballos-Garzon, A. | Roman, E. | Pla, J. | Pagniez, F. | Amado, D. | Alméciga-Díaz, C. J. | Le Pape, P. | Parra-Giraldo, C. M.

https://doi.org/10.1371/journal.pone.0265777

P247

Int. J. Antimicrob. Agents. 2022. 

Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing.

Ceballos-Garzon, A. | Garcia-Effron, G. | Cordoba, S. | Rodriguez, J. Y. | Alvarez-Moreno, C. | Le Pape, P. | Parra-Giraldo, C. M. | Morales-López, S.

https://doi.org/10.1016/j.ijantimicag.2022.106558

P245

J. Antimicrob. Chemother. 2022, 77, 585–597. 

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.

Ceballos-Garzon, A. | Monteoliva, L. | Gil, C. | Alvarez-Moreno, C. | Vega-Vela, N. E. | Engelthaler, D. M. | Bowers, J. | Le Pape, P. | Parra-Giraldo, C. M.

https://doi.org/10.1093/jac/dkab454

P210

 J. Antimicrob. Chemother. 2020, 75, 1187-1193.

Impact of Calmodulin Inhibition by Fluphenazine on Susceptibility, Biofilm Formation and Pathogenicity of Caspofungin-Resistant Candida glabrata.

Ceballos-Garzon, A. | Amado, D. | Robert, E. | Parra-Giraldo, C. M. | Le Pape, P.

doi: 10.1093/jac/dkz565

Autres publications scientifiques

Brevets

Thèse